Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

prnasiaJanuary 25, 2021

Tag: BAVENCIO , UC , Merck , Pfizer , avelumab

PharmaSources Customer Service